Hiroshi Tanabe

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Toru Sugiyama, Aikou Okamoto, Takayuki Enomoto et al. · Journal of Clinical Oncology · 2016 · 139 citations

Preoperative diagnosis of malignant transformation arising from mature cystic teratoma of the ovary

Yukiko Mori, H Nishii, Kazuaki Takabe et al. · Gynecologic Oncology · 2003 · 105 citations

Surgical Pathology, Malignant Transformation, Gynecology +5

Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes

Ryusuke Murakami, Noriomi Matsumura, Masaki Mandai et al. · American Journal Of Pathology · 2016 · 97 citations · Full text

Novel Histopathological Classification, Medicine, Histopathology +7

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Shoji Nagao, Shin Nishio, Hirofumi Michimae et al. · Gynecologic Oncology · 2013 · 75 citations

Sgsg-012/gotic-004/intergroup Study, Medicine, Cancer Management +7

Randomized controlled trial of enoxaparin versus intermittent pneumatic compression for venous thromboembolism prevention in Japanese surgical patients with gynecologic malignancy

Chie Nagata, Hiroshi Tanabe, Satoshi Takakura et al. · Journal of obstetrics and gynaecology research · 2015 · 39 citations